RBC Capital raises target on revenue beat Jazz Pharmaceuticals' stock price target has been raised due to a revenue beat. The company's revenue exceeded expectations, prompting the target increase. The raised target reflects the company's strong financial perform
RBC Capital raises target on revenue beat
Jazz Pharmaceuticals’ stock price target has been raised due to a revenue beat.
The company’s revenue exceeded expectations, prompting the target increase.
The raised target reflects the company’s strong financial performance.
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.
